Anna Pagonakis

Array ( [id] => 5509224 [patent_doc_number] => 20090082431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/044870 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 30921 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082431.pdf [firstpage_image] =>[orig_patent_app_number] => 12044870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676878 [patent_doc_number] => 20080214509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Methods for enhancing the efficacy of vascular disrupting agents' [patent_app_type] => utility [patent_app_number] => 12/074555 [patent_app_country] => US [patent_app_date] => 2008-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22801 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214509.pdf [firstpage_image] =>[orig_patent_app_number] => 12074555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509218 [patent_doc_number] => 20090082425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'COMPOUNDS FROM MYROTHECIUM SP. FOR INHIBITING THE GROWTH OF CANCER CELLS' [patent_app_type] => utility [patent_app_number] => 12/040157 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4161 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082425.pdf [firstpage_image] =>[orig_patent_app_number] => 12040157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282963 [patent_doc_number] => 08217071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Use of inhibitors of the degradation of p27, in particular Argyrin and derivatives thereof, for the treatment of proliferative diseases' [patent_app_type] => utility [patent_app_number] => 12/527428 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10376 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12527428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720194 [patent_doc_number] => 20080242717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA' [patent_app_type] => utility [patent_app_number] => 12/038598 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7506 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242717.pdf [firstpage_image] =>[orig_patent_app_number] => 12038598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8797116 [patent_doc_number] => 08435984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Tertiary amine substituted peptides useful as inhibitors of HCV replication' [patent_app_type] => utility [patent_app_number] => 12/597380 [patent_app_country] => US [patent_app_date] => 2008-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18154 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12597380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596275 [patent_doc_number] => 07981939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization' [patent_app_type] => utility [patent_app_number] => 12/072496 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 16 [patent_no_of_words] => 4695 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981939.pdf [firstpage_image] =>[orig_patent_app_number] => 12072496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596275 [patent_doc_number] => 07981939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization' [patent_app_type] => utility [patent_app_number] => 12/072496 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 16 [patent_no_of_words] => 4695 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981939.pdf [firstpage_image] =>[orig_patent_app_number] => 12072496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880475 [patent_doc_number] => 20080153858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'ANTITUMORIGENIC DRUG COMBINATION' [patent_app_type] => utility [patent_app_number] => 11/958880 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4196 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153858.pdf [firstpage_image] =>[orig_patent_app_number] => 11958880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728019 [patent_doc_number] => 20080207563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'METHOD FOR INHIBITING PROLIFERATION OF TUMOR CELLS' [patent_app_type] => utility [patent_app_number] => 12/034694 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 37682 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207563.pdf [firstpage_image] =>[orig_patent_app_number] => 12034694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4814046 [patent_doc_number] => 20080194677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Transdermal fluid' [patent_app_type] => utility [patent_app_number] => 12/068798 [patent_app_country] => US [patent_app_date] => 2008-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5004 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194677.pdf [firstpage_image] =>[orig_patent_app_number] => 12068798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4726653 [patent_doc_number] => 20080206194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Method for the treatment of breast cancer' [patent_app_type] => utility [patent_app_number] => 12/069695 [patent_app_country] => US [patent_app_date] => 2008-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3723 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206194.pdf [firstpage_image] =>[orig_patent_app_number] => 12069695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867603 [patent_doc_number] => 20080146662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Methods and compositions for treatment of cancer pain' [patent_app_type] => utility [patent_app_number] => 12/025351 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3973 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146662.pdf [firstpage_image] =>[orig_patent_app_number] => 12025351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955520 [patent_doc_number] => 20080188544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'LYOPHILIZED FORMULATIONS OF SALINOSPORAMIDE A' [patent_app_type] => utility [patent_app_number] => 12/025679 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 10604 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188544.pdf [firstpage_image] =>[orig_patent_app_number] => 12025679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497697 [patent_doc_number] => 20100286151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => '1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating Disorders' [patent_app_type] => utility [patent_app_number] => 12/524080 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44971 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286151.pdf [firstpage_image] =>[orig_patent_app_number] => 12524080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484861 [patent_doc_number] => 20090274626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'TARGETING TNF-alpha CONVERTING ENZYME(TACE)- DEPENDENT GROWTH FACTOR SHEDDING IN CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/022049 [patent_app_country] => US [patent_app_date] => 2008-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19893 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274626.pdf [firstpage_image] =>[orig_patent_app_number] => 12022049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845563 [patent_doc_number] => 20080181971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Combination Cancer Treatments Comprising Elsamitrucin and Other Agents' [patent_app_type] => utility [patent_app_number] => 12/020338 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18423 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181971.pdf [firstpage_image] =>[orig_patent_app_number] => 12020338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4486584 [patent_doc_number] => 07884098 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-08 [patent_title] => 'Anthranilamide inhibitors of aurora kinase' [patent_app_type] => utility [patent_app_number] => 12/524009 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17838 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/884/07884098.pdf [firstpage_image] =>[orig_patent_app_number] => 12524009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846444 [patent_doc_number] => 20080182852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'ANTHRANILAMIDE INHIBITORS OF AURORA KINASE' [patent_app_type] => utility [patent_app_number] => 12/019730 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17857 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182852.pdf [firstpage_image] =>[orig_patent_app_number] => 12019730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585998 [patent_doc_number] => 20090105200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Combination therapy' [patent_app_type] => utility [patent_app_number] => 12/009867 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14195 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105200.pdf [firstpage_image] =>[orig_patent_app_number] => 12009867 [rel_patent_id] =>[rel_patent_doc_number] =>)